Cn. Ellis et al., COMPARISON OF ADAPALENE 0.1-PERCENT SOLUTION AND TRETINOIN 0.025-PERCENT GEL IN THE TOPICAL TREATMENT OF ACNE-VULGARIS, British journal of dermatology, 139, 1998, pp. 41-47
A multicentre study was conducted to compare clinical safety and effic
acy of adapalene 0.1% solution and tretinoin 0.025% gel, both topical
treatments for acne, in a once-daily dosage regimen for 12 weeks. A to
tal of 297 patients were enrolled by eight investigators in this rando
mized, investigator-masked study in a parallel group design. An open l
abel period using adapalene followed this study to assess the long-ter
m safety of adapalene solution. Adapalene and tretinoin proved to be c
linically and statistically effective in treating acne by reducing inf
lammatory (47% and 50%, respectively) and non-inflammatory lesions (57
% and 54%) as compared to baseline. When comparing patients who had 75
% or greater improvement in open comedones, adapalene was shown to be
significantly more effective than tretinoin. No serious adverse event
was reported during this study, including during the long-term period.
The reactions that occurred were similar between treatments, i.e, bur
ning, pruritus, scaling, dryness and erythema.